Now, a federal study that pools these folks gives them strength in numbers and new options. Brigitte Sagasser, 54, of San Marcos, California, is one study participant who seems to be benefiting. “We’re trying to fill that gap” by funding the federal study, said Dr. Elad Sharon of the National Cancer Institute. In the study of 32 patients, the drug combo only worked for high-grade tumors. “It gives us a glimpse into what can happen,” said another study leader, Dr. Razelle Kurzrock at the San Diego cancer centre.

Source: National Post April 01, 2019 16:18 UTC